Medifast (MED) Projected to Post Quarterly Earnings on Tuesday

Medifast (NYSE:MED) is projected to release its earnings data after the market closes on Tuesday, February 18th. Analysts expect Medifast to post earnings of ($0.16) per share and revenue of $114.25 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Medifast Stock Up 0.7 %

Shares of NYSE:MED opened at $15.19 on Tuesday. The firm has a fifty day moving average price of $17.13 and a two-hundred day moving average price of $18.28. The company has a market cap of $166.17 million, a price-to-earnings ratio of 23.01 and a beta of 1.14. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.11 and a quick ratio of 2.55. Medifast has a one year low of $14.88 and a one year high of $56.52.

Analyst Upgrades and Downgrades

Separately, DA Davidson upgraded Medifast from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $16.50 to $17.00 in a research report on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.